1. Clinical significance of topoisomerase‐II expression in patients with advanced non‐small cell lung cancer treated with amrubicin. Issue 2 (3rd January 2020) Authors: Sakurai, Reiko; Kaira, Kyoichi; Miura, Yosuke; Sunaga, Noriaki; Saito, Ryusei; Oyama, Tetsunari; Hisada, Takeshi; Yamada, Masanobu Journal: Thoracic cancer Issue: Volume 11:Issue 2(2020) Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non‐small cell lung cancer receiving EGFR‐TKI treatment. Issue 8 (3rd June 2020) Authors: Kasahara, Norimitsu; Imai, Hisao; Naruse, Ichiro; Tsukagoshi, Yusuke; Kotake, Mie; Sunaga, Noriaki; Kaira, Kyoichi; Maeno, Toshitaka; Asao, Takayuki; Hisada, Takeshi Journal: Thoracic cancer Issue: Volume 11:Issue 8(2020) Page Start: 2188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations. Issue 8 (11th June 2020) Authors: Masuda, Tomomi; Sunaga, Noriaki; Kasahara, Norimitsu; Takehara, Kazutaka; Yatomi, Masakiyo; Hara, Kenichiro; Koga, Yasuhiko; Maeno, Toshitaka; Hisada, Takeshi Journal: Thoracic cancer Issue: Volume 11:Issue 8(2020) Page Start: 2351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗